In COVID-19 with hypoxemia, 12 vs. 6 mg/d of dexamethasone did not increase days alive without life support

Michael J Jacka

doi:10.7326/J22-0001

In COVID-19 with hypoxemia, 12 vs. 6 mg/d of dexamethasone did not increase days alive without life support

Ann Intern Med. 2022 Mar;175(3):JC33. doi: 10.7326/J22-0001. Epub 2022 Mar 1.

Author

Michael J Jacka¹

Affiliation

¹ University of Alberta, Edmonton, Alberta, Canada (M.J.J.).

PMID: 35226531
DOI: 10.7326/J22-0001

Abstract

Munch MW, Myatra SN, Vijayaraghavan BK, et al. Effect of 12 mg vs 6 mg of dexamethasone on the number of days alive without life support in adults with COVID-19 and severe hypoxemia: the COVID STEROID 2 randomized trial. JAMA. 2021;326:1807-17. 34673895.

Publication types

Comment

MeSH terms

Adult
COVID-19 Drug Treatment*
Dexamethasone / adverse effects
Humans
Hypoxia
SARS-CoV-2

Substances

Dexamethasone